INOTEK PHARMACEUTICALS CORP's ticker is ITEK and the CUSIP is 45780V102.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $1,399,000 | +23.7% | 535,984 | -15.7% | 0.01% | +20.0% |
| Q3 2017 | $1,131,000 | -86.4% | 635,465 | -27.8% | 0.01% | -91.5% |
| Q3 2016 | $8,342,000 | +29.8% | 880,000 | +1.9% | 0.06% | +34.1% |
| Q2 2016 | $6,428,000 | -13.4% | 864,000 | -13.9% | 0.04% | -22.8% |
| Q1 2016 | $7,425,000 | -42.9% | 1,003,402 | -12.6% | 0.06% | -46.7% |
| Q4 2015 | $13,008,000 | +14.9% | 1,148,100 | -4.7% | 0.11% | +20.2% |
| Q3 2015 | $11,326,000 | – | 1,204,906 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Devon Park Associates, LLC | 3,243,709 | $36,751,000 | 100.00% |
| RHO CAPITAL PARTNERS INC | 2,627,790 | $29,773,000 | 10.24% |
| Private Capital Advisors, Inc. | 341,000 | $3,864,000 | 1.67% |
| NEXTHERA CAPITAL LP | 42,000 | $476,000 | 0.68% |
| SPHERA FUNDS MANAGEMENT LTD. | 360,000 | $4,079,000 | 0.60% |
| SENZAR ASSET MANAGEMENT, LLC | 309,600 | $3,507,768,000 | 0.39% |
| Graticule Asia Macro Advisors LLC | 148,000 | $1,676,000 | 0.27% |
| FT Options LLC | 26,421 | $299,000 | 0.22% |
| EAM Investors, LLC | 128,911 | $1,461,000 | 0.19% |
| Tekla Capital Management LLC | 425,000 | $4,815,000 | 0.18% |